Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012. Issue 2 (3rd January 2015)

• Record Type: Journal Article
• Authors: Lepoutre, A.; Varon, E.; Georges, S.; Dorléans, F.; Janoir, C.; Gutmann, L.; Lévy-Bruhl, D.; the Microbiologists of the Epibac, 1; the ORP Networks, 2
• Is Part Of: Vaccine. Volume 33:Issue 2(2015)
• Page Start: 359
• Page End: 366
• Publication Date: 2015-01-03
• Subjects: Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2014.11.011
• Languages: English
• ISSNs: 0264-410X

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0010"> <label></label> <p id="par0010">PCVs coverage increased from 56% in those born in 2004 to 94% in those born in 2008.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">After PCV7, IPD decreased in children &lt;2 years, but not in older age-groups.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">After PCV13, IPD declined in children &lt;2 years, and in other non-targeted age-groups.</p> </list-item> <list-item id="lsti0025"> <label></label> <p id="par0025">For the whole PCV7 + PCV13 period, IPD declined only in children aged 0–4 years.</p> </list-item> </list> </p> </sec> </abstract>